coronavirus
cov
rna
virus
infect
human
anim
infect
involv
respiratori
gastrointestin
central
nervou
system
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
infecti
lethal
caus
thousand
death
past
two
decad
recent
outbreak
discov
wuhan
china
highli
contagi
diseas
spread
throughout
china
countri
although
antivir
therapi
corticosteroid
therapi
mechan
respiratori
support
appli
lack
specif
treatment
melatonin
bioactiv
molecul
array
healthpromot
properti
melatonin
success
use
treat
sleep
disord
delirium
atherosclerosi
respiratori
diseas
viral
infect
previou
research
document
posit
effect
melatonin
allevi
acut
respiratori
stress
induc
viru
bacteria
radiat
etc
herein
review
evid
indic
melatonin
support
adjuv
util
treat
induc
pneumonia
acut
lung
injuri
ali
acut
respiratori
distress
syndrom
ard
patient
infect
report
present
fever
dri
cough
myalgia
fatigu
diarrhea
etc
symptom
vari
somewhat
patient
age
case
sever
progress
diseas
result
aliard
respiratori
failur
heart
failur
sepsi
sudden
cardiac
arrest
within
day
pathogen
examin
lung
specimen
mild
patient
retrospect
found
time
lung
cancer
surgeri
show
edema
proteinac
exud
globul
patchi
inflammatori
cellular
infiltr
moder
format
hyalin
membran
postmortem
assess
patient
sever
ard
specimen
infect
lung
demonstr
bilater
diffus
alveolar
damag
edema
pneumocyt
desquam
hyalin
membran
format
though
patholog
report
report
small
number
case
find
resembl
patholog
featur
found
sarsand
mersinduc
pneumonia
sarscov
merscov
classifi
betacoronaviru
famili
member
recent
publish
research
suggest
share
nucleotid
ident
sarscov
ident
merscov
indic
high
genet
homolog
among
merscov
sarscov
sarscov
merscov
infect
anim
model
mark
inflammatori
immun
respons
may
activ
cytokin
storm
apoptosi
epitheli
cell
endotheli
cell
subsequ
vascular
leakag
abnorm
cell
macrophag
respons
ensu
induc
aliard
even
death
base
genet
homolog
patholog
featur
infect
lung
predict
cytokin
storm
also
prevail
patient
blood
patient
mark
increas
interleukin
interferon
interferoninduc
protein
monocyt
chemoattract
protein
well
compar
sar
patient
suggest
potenti
differ
sar
mer
pathogenesi
coronaviru
also
potenti
repress
immun
function
patient
hypoalbuminemia
lymphopenia
neutropenia
decreas
percentag
cell
recent
report
suggest
patient
although
neg
viral
nucleic
acid
test
still
sometim
present
high
level
inflamm
clinic
trial
use
certolizumab
pegol
tnf
blocker
along
antiviru
therapi
may
benefici
effect
patient
collect
find
indic
inflamm
major
featur
patient
thu
hypothes
excess
inflamm
depress
immun
system
activ
cytokin
storm
substanti
contribut
pathogenesi
earli
stage
coronavirus
infect
dendrit
cell
epitheli
cell
activ
express
cluster
proinflammatori
cytokin
chemokin
includ
tumor
necrosi
factor
tnf
cec
motif
chemokin
etc
control
immun
system
thu
overproduct
cytokin
chemokin
contribut
develop
diseas
produc
antivir
infect
coronavirus
lead
mark
decreas
agent
interestingli
patient
sometim
significantli
elev
level
whether
featur
infect
result
medic
treatment
unknown
amplif
inflammatori
respons
would
promot
cellular
apoptosi
postul
lung
infect
suppress
immun
respons
elev
inflamm
excess
oxid
stress
proceed
unab
result
activ
cytokin
storm
aliard
may
ensu
accompani
seri
complic
outcom
vari
accord
sever
diseas
melatonin
may
play
role
adjuv
medic
regul
immun
system
inflamm
oxid
stress
provid
support
patient
aliard
relat
complic
ali
acut
lung
injuri
ard
acut
respiratori
distress
syndrom
necrosi
affect
cell
would
fuel
inflamm
follow
increas
permeabl
blood
vessel
aberr
accumul
inflammatori
monocyt
macrophag
neutrophil
lung
alveoli
viciou
circl
would
intensifi
situat
regul
immun
respons
lost
cytokin
storm
activ
result
dire
consequ
put
cytokin
storm
patholog
associ
coronavirus
also
support
experiment
sarscov
model
one
show
sever
ali
accompani
elev
express
inflammationrel
gene
rather
increas
viral
titer
anoth
case
ablat
receptor
deplet
inflammatori
monocytesmacrophag
caus
mark
rise
surviv
rate
coronavirus
host
without
chang
viral
load
situat
suggest
potenti
amplifi
mechan
involv
covinduc
aliard
regardless
viral
load
similar
patholog
also
exist
attenu
cytokin
storm
target
sever
key
step
process
could
bring
improv
outcom
melatonin
viricid
indirect
antivir
action
due
antiinflamm
antioxid
immun
enhanc
featur
situat
melatonin
suppress
featur
viral
infect
mice
whose
central
nervou
system
infect
viru
eg
enceph
use
melatonin
caus
less
viremia
reduc
paralysi
death
decreas
viru
load
previou
respiratori
syncyti
viru
model
melatonin
caus
downregul
acut
lung
oxid
injuri
proinflammatori
cytokin
releas
inflammatori
cell
recruit
find
along
recent
summar
reiter
et
al
support
rational
melatonin
use
viral
diseas
also
melatonin
antiinflamm
antioxid
immun
enhanc
action
support
potenti
attenu
infect
fig
melatonin
exert
antiinflammatori
effect
variou
pathway
may
mediat
antiinflammatori
action
melatonin
inhibit
high
mobil
group
boxechromosom
protein
thu
downregul
polar
macrophag
toward
proinflammatori
type
sepsisinduc
ali
proper
regul
attenu
lung
injuri
inflamm
applic
melatonin
might
benefici
nuclear
factor
kappab
close
associ
proinflammatori
prooxid
respons
inflammatori
mediat
ali
antiinflammatori
effect
melatonin
involv
suppress
activ
ard
melatonin
reportedli
downregul
activ
cell
lung
tissu
stimul
factor
crucial
protect
lung
injuri
relat
studi
melatonin
induc
upregul
therapeut
effect
hepatoprotect
cardioprotect
etc
whether
involv
covinduc
ali
remain
unknown
close
interact
suggest
particip
covinduc
aliard
data
support
potenti
antiinflammatori
action
melatonin
inflamm
commonli
associ
elev
product
cytokin
chemokin
melatonin
caus
reduct
proinflammatori
cytokin
elev
level
antiinflammatori
cytokin
may
howev
concern
potenti
proinflammatori
action
melatonin
use
high
dose
suppress
immun
condit
may
induc
increas
product
proinflammatori
cytokin
convers
ali
infect
model
melatonin
present
antiinflammatori
protect
action
antioxid
effect
melatonin
cooper
antiinflammatori
action
upregul
antioxid
enzym
eg
superoxid
dismutas
downregul
prooxid
enzym
eg
nitric
oxid
synthas
may
also
interact
directli
free
radic
function
free
radic
scaveng
viral
infect
replic
constantli
gener
oxid
product
sarsinduc
ali
model
product
oxid
low
densiti
lipoprotein
activ
innat
immun
respons
overproduct
alveolar
macrophag
via
tolllik
receptor
nfkb
signal
therebi
lead
ali
receptor
innat
immun
system
also
therapeut
target
melatonin
brain
ischemia
gastriti
periodont
diseas
model
melatonin
document
antiinflamm
action
via
signal
antioxid
effect
melatonin
also
confirm
ali
caus
radiat
sepsi
ischemiareperfus
aliard
patient
especi
diseas
advanc
patient
treat
intens
care
unit
icu
sever
inflamm
hypoxemia
mechan
ventil
high
oxygen
concentr
inevit
increas
oxid
gener
local
systemat
accordingli
specul
excess
oxid
also
like
involv
extens
studi
gitto
et
al
use
melatonin
treat
newborn
infant
respiratori
distress
document
antioxid
antiinflammatori
action
melatonin
lung
thu
like
applic
melatonin
would
benefici
control
inflamm
oxid
coronaviru
infect
subject
viru
inhal
infect
respiratori
epitheli
cell
dendrit
cell
phagocytos
viru
present
antigen
cell
effector
cell
function
kill
infect
epitheli
cell
cytotox
cell
produc
releas
proinflammatori
cytokin
induc
cell
apoptosi
pathogen
cov
cell
apoptosi
trigger
amplifi
immun
respons
exacerb
cytokin
product
excess
recruit
immun
cell
uncontrol
epitheli
damag
gener
viciou
circl
infect
relat
aliard
clinic
characterist
suggest
reduc
level
neutrophil
lymphocyt
cell
peripher
blood
melatonin
exert
regulatori
action
immun
system
directli
enhanc
immun
respons
improv
prolifer
matur
natur
kill
cell
b
lymphocyt
granulocyt
monocyt
bone
marrow
tissu
macrophag
antigen
present
also
augment
applic
melatonin
upregul
complement
receptor
mhc
class
class
ii
antigen
detect
nodlik
receptor
inflammasom
part
innat
immun
respons
lung
infect
pathogen
includ
viru
cov
yet
test
trigger
activ
amplifi
inflamm
probabl
balanc
protect
damag
action
lung
thu
mous
experi
inhibit
earli
phase
infect
increas
mortal
wherea
suppress
peak
infect
allow
protect
effect
support
use
melatonin
aliard
inflamm
sever
inflammasom
correl
lung
diseas
caus
infect
includ
influenza
viru
syncyti
viru
bacteria
efficaci
melatonin
regul
proven
radiationinduc
lung
injuri
allerg
airway
inflamm
oxygeninduc
ali
lpsinduc
ali
model
melatonin
reduc
infiltr
macrophag
neutrophil
lung
ali
due
inhibit
inflammasom
although
obvious
report
relat
use
melatonin
patient
subject
diseas
increas
level
inflamm
applic
melatonin
show
promis
result
regard
attenu
circul
cytokin
level
random
control
trial
oral
intak
mgd
melatonin
caus
signific
decreas
serum
level
hscreactiv
protein
hscrp
patient
diabet
mellitu
periodont
anoth
trial
patient
suffer
sever
multipl
sclerosi
oral
mgd
melatonin
month
also
promot
signific
reduct
serum
concentr
lipoperoxid
acut
phase
inflamm
includ
surgic
stress
brain
reperfus
coronari
arteri
reperfus
melatonin
intak
mgd
mgd
mgd
melatonin
less
day
induc
reduc
level
proinflammatori
cytokin
recent
metaanalysi
total
random
control
trial
suggest
supplementari
use
melatonin
associ
signific
reduct
level
clinic
evid
suggest
use
melatonin
supplement
may
effect
reduc
level
circul
cytokin
may
potenti
also
lower
proinflammatori
cytokin
level
patient
integr
vascular
endotheli
barrier
crucial
immunoregul
within
alveoli
sever
inflamm
immun
respons
induc
epitheli
endotheli
cell
apoptosi
well
increas
product
vegf
aggrav
edema
extravas
immun
cell
blood
vessel
experiment
evid
suggest
melatonin
mediat
suppress
vegf
vascular
endotheli
cell
base
clinic
report
patient
sever
aliard
may
also
increas
risk
sepsi
cardiac
arrest
publish
report
indic
applic
melatonin
may
amelior
septic
shock
via
pathway
specif
melatonin
may
prevent
effect
sepsisinduc
renal
injuri
septic
cardiomyopathi
liver
injuri
also
report
melatonin
benefit
patient
myocardi
infarct
cardiomyopathi
hypertens
heart
diseas
pulmonari
hypertens
probabl
function
via
activ
factor
enhanc
pathway
moreov
melatonin
exert
neurolog
protect
reduc
cerebr
inflammatori
respons
cerebr
edema
brainblood
barrier
permeabl
number
experiment
condit
icu
deep
sedat
associ
increas
longterm
mortal
applic
melatonin
reduc
sedat
use
frequenc
pain
agit
anxieti
also
recent
metaanalysi
show
melatonin
improv
sleep
qualiti
patient
icu
thu
rational
use
melatonin
patient
focus
attenu
infectioninduc
respiratori
disord
also
overal
improv
prevent
patient
wellb
potenti
complic
consid
use
melatonin
treat
safeti
melatonin
utmost
signific
consid
review
previous
shortterm
use
melatonin
safe
even
given
high
dose
report
advers
effect
limit
occasion
dizzi
headach
nausea
sleepi
gener
melatonin
safeti
human
high
clinic
trial
dose
mg
mg
mg
melatonin
oral
intak
patient
icu
show
satisfactori
safeti
compar
placebo
also
even
melatonin
given
human
dose
gd
month
advers
report
treatment
final
advers
effect
record
use
melatonin
aliard
anim
studi
safeti
melatonin
verifi
mani
human
studi
effect
given
patient
care
monitor
despit
high
safeti
profil
melatonin
possibl
benefici
effect
melatonin
adjuv
use
antiinflamm
antioxid
immun
respons
regul
repeatedli
demonstr
respiratori
disord
model
induc
infect
associ
complic
melatonin
high
safeti
profil
although
direct
evid
melatonin
applic
unclear
use
experiment
anim
model
studi
human
continu
document
efficaci
safeti
use
patient
predict
would
highli
benefici
